Related Experiment Video
Updated: May 28, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A
Hanan Alshareef1, Khalidah A Alenzi2, Budor R Albalawi3
1Pharmacy Practice Department, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Background:
Fluoroquinolones (FQs) are among the most popular antimicrobials that are highly effective against various infections. Although FQs are the most frequently used and generally tolerated, there are issues with their safety. This study assessed the rate, severity, seriousness, outcomes, and types of FQs adverse drug reactions (ADRs) in reports submitted to a regional spontaneous ADR database.
Methods:
This was a retrospective cross-sectional observational study involving all patients with reported ADRs related to FQs or other antibiotics (ABs) that were submitted to the Regional Pharmacovigilance Center (PVC) database between January 2019 and December 2022. Data were extracted in the form of Saudi ADR from the PVC database, which is consistent with the MedWatch ADR form of the U.S Food and Drug Authority (FDA).
Results:
In total, 605 ADRs related to antibiotic use were reported. ADRs caused by FQs use were the most frequently reported (177; 29.3%), followed by penicillin (100; 23.4%) and cephalosporin (90; 21%). There was no significant difference in ADRs caused by FQs between men (104; 58%) and women (OR 1.17, 95% CI 0.82-1.67, p=0.386). FQ-related ADRs were more frequent among those over 40 years-old (OR 1.56, 95% CI 1.09-2.22, p=0.015). Most of the detected FQ-related ADRs were of moderate severity (157; 88.7%), required interventions (83; 46.9%), and recovered after receiving medical interventions (154; 87%). Patients who received FQs were fourfold more likely to experience neurological adverse events (OR 4.15, 95% CI 2.48-6.93, p <0.001).
Conclusion:
The FQs drug class exhibited a higher incidence of ADRs than other ABs. Regularly assessing the safety of ABs is crucial to improve public and healthcare providers' awareness of the correct utilization of ABs and to limit the use of FQs to infections that cannot be effectively managed with alternative ABs.
Insights
Fluoroquinolones (FQs) cause the most reported antibiotic adverse drug reactions (ADRs), particularly neurological events in patients over 40. Regular safety assessments are vital for appropriate antibiotic use.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Antimicrobial Therapy
Background:
- Fluoroquinolones (FQs) are widely used antimicrobials with known safety concerns.
- Adverse drug reactions (ADRs) associated with FQs require thorough investigation.
- This study focuses on FQ ADRs reported in a regional database.
Purpose of the Study:
- To assess the incidence, severity, and types of FQ-related ADRs.
- To compare FQ ADRs with those of other antibiotics.
- To identify patient demographics and outcomes associated with FQ ADRs.
Main Methods:
- Retrospective cross-sectional observational study.
- Analysis of ADR reports submitted to a Regional Pharmacovigilance Center (PVC) database (January 2019 - December 2022).
- Data extraction using Saudi ADR forms, consistent with FDA's MedWatch.
Main Results:
- Fluoroquinolones accounted for the highest proportion of reported antibiotic ADRs (29.3%).
- FQ-related ADRs were more common in individuals over 40 years old.
- Neurological adverse events were significantly more likely in patients receiving FQs (OR 4.15).
- Most FQ ADRs were of moderate severity and resolved after medical intervention.
Conclusions:
- The fluoroquinolone class shows a higher incidence of ADRs compared to other antibiotics.
- Continuous safety monitoring of antibiotics is essential.
- Promoting awareness and judicious use of FQs for infections unresponsive to alternatives is recommended.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Drug Regulation
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

